[Correction of hyperlipoproteinogenic microangiopathy and organ pathology at early stages of atherogenesis with thymalin and leu-enkephalin].
Pozdniakov
O M
OM
Klimenko
E D
ED
Kobozeva
L P
LP
Michunskaia
A B
AB
Khabarina
I Iu
IIu
D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D004743:Enkephalin, Leucine / Q000627:therapeutic use*; D006951:Hyperlipoproteinemias / Q000150:complications*; D050356:Lipid Metabolism; D015227:Lipid Peroxidation; D008099:Liver / Q000473:pathology; D008297:Male; D008833:Microcirculation; D009206:Myocardium / Q000473:pathology; D011817:Rabbits; D013951:Thymus Hormones / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000473:pathology
D013951:Thymus Hormones; D004743:Enkephalin, Leucine; C032805:thymalin
Korrektsiia timalinom i leĭ énkefalinom giperlipoproteidogennoĭ mikroangiopatii i organnoĭ patologii na rannikh stadiiakh aterogeneza.